Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.56 - $1.17 $76,647 - $160,137
-136,870 Reduced 85.32%
23,541 $13,000
Q1 2023

May 15, 2023

SELL
$1.02 - $1.39 $13,806 - $18,815
-13,536 Reduced 7.78%
160,411 $183,000
Q4 2022

Feb 14, 2023

BUY
$1.02 - $1.61 $11,953 - $18,867
11,719 Added 7.22%
173,947 $195,000
Q3 2022

Nov 14, 2022

BUY
$1.28 - $2.91 $146,051 - $332,039
114,103 Added 237.1%
162,228 $341,000
Q2 2022

Aug 15, 2022

BUY
$1.21 - $1.81 $58,231 - $87,106
48,125 New
48,125 $65,000
Q1 2022

May 16, 2022

SELL
$1.03 - $2.01 $44,866 - $87,555
-43,560 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$0.98 - $3.06 $82,322 - $257,049
-84,003 Reduced 65.85%
43,560 $47,000
Q3 2021

Nov 15, 2021

SELL
$2.79 - $4.19 $90,889 - $136,497
-32,577 Reduced 20.34%
127,563 $376,000
Q2 2021

Aug 16, 2021

BUY
$2.8 - $3.78 $448,392 - $605,329
160,140 New
160,140 $482,000
Q2 2020

Aug 14, 2020

SELL
$2.83 - $6.99 $1.18 Million - $2.93 Million
-418,646 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$3.18 - $7.0 $1.33 Million - $2.93 Million
418,646 New
418,646 $1.33 Million
Q4 2019

Feb 14, 2020

SELL
$3.46 - $7.7 $242,975 - $540,724
-70,224 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$2.8 - $3.99 $132,017 - $188,124
-47,149 Reduced 40.17%
70,224 $269,000
Q2 2019

Aug 15, 2019

SELL
$2.34 - $4.28 $2.89 Million - $5.28 Million
-1,233,216 Reduced 91.31%
117,373 $446,000
Q2 2019

Aug 14, 2019

BUY
$2.34 - $4.28 $2.59 Million - $4.74 Million
1,108,474 Added 457.83%
1,350,589 $22.5 Million
Q1 2019

May 14, 2019

SELL
$3.6 - $8.75 $321,181 - $780,648
-89,217 Reduced 26.93%
242,115 $872,000
Q4 2018

Feb 14, 2019

BUY
$6.25 - $9.2 $2.07 Million - $3.05 Million
331,332 New
331,332 $2.57 Million

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0

About RVL Pharmaceuticals plc


  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.